Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -238.27x is 90% below its 5-year average of -125.15x, near the high end of its 5-year range (-1307.61x–-0.63x).
17.24% above its 12-month average of -287.89x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -285.32x.
INTEREST COVERAGE RATIO
-238.27x
INTEREST COVERAGE RATIO AVG TTM
-287.89x
INTEREST COVERAGE RATIO AVG 3Y
-195.68x
INTEREST COVERAGE RATIO AVG 5Y
-125.15x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+17.24%
CURRENT VS 3Y AVG
-21.77%
CURRENT VS 5Y AVG
-90.39%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 476 covered companies
CURRENT VS SECTOR MEDIAN
-4015.20%
vs the sector median at left
bioAffinity Technologies, Inc.
Market Cap
$2.58M
Interest Coverage Ratio
-238.27x
TTM Avg
-287.89x
3Y Avg
-195.68x
5Y Avg
-125.15x
Market Cap
$2.56M
Interest Coverage Ratio
673.25x
TTM Avg
673.25x
3Y Avg
673.25x
5Y Avg
673.25x
Market Cap
$2.45M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.54M
Interest Coverage Ratio
-81.61x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.61M
Interest Coverage Ratio
-1.05x
TTM Avg
65.98x
3Y Avg
65.98x
5Y Avg
65.98x
Market Cap
$2.67M
Interest Coverage Ratio
-4606.42x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.31M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.33M
Interest Coverage Ratio
-168.25x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.58M | -238.27x | -287.89x | -195.68x | -125.15x |
| Jaguar Health, Inc. (JAGX)vs › | $2.56M | 673.25x | 673.25x | 673.25x | 673.25x |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.45M | N/A | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.54M | -81.61x | N/A | N/A | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.61M | -1.05x | 65.98x | 65.98x | 65.98x |
| iSpecimen Inc. (ISPC)vs › | $2.67M | -4606.42x | N/A | N/A | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.35M | -8.45x | N/A | N/A | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.31M | N/A | N/A | N/A | N/A |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.33M | -168.25x | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.28M | N/A | N/A | N/A | N/A |
Interest Coverage
-238.3x
Debt/Equity
0.38
Current Ratio
1.44
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -285.32x |
| 2026-03-31 | -245.69x |
| 2025-12-31 | -240.03x |
| 2025-09-30 | -427.93x |
| 2025-06-30 | -240.49x |
| 2025-03-31 | -169.66x |
| 2024-12-31 | -117.65x |
| 2024-09-30 | -91.25x |
| 2024-06-30 | -93.84x |
| 2024-03-31 | -82.60x |
| 2023-12-31 | -92.50x |
| 2023-09-30 | -261.18x |
| 2023-06-30 | -1307.61x |
| 2023-03-31 | -941.37x |
| 2022-12-31 | -16.79x |
| 2022-09-30 | -1.10x |
| 2022-06-30 | -1.71x |
| 2022-03-31 | -0.63x |
| 2021-12-31 | -1.03x |
| 2021-09-30 | -3.89x |
| 2021-06-30 | -4.53x |
| 2021-03-31 | -4.40x |
